EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Notch Inhibitors and BH3 Mimetics in T-Cell Acute Lymphoblastic Leukemia

Ilaria Sergio iD, Claudia Varricchio, Federica Squillante, Noemi Martina Cantale Aeo, Antonio Francesco Campese, Maria Pia Felli iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms252312839 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Ilaria Sergio und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Medicine, Sapienza University of Rome, 00161 Rome, Italy. Hauptthemen laut MEDLINE: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Receptors, Notch, Apoptosis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 130 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sapienza University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive hematological malignancy with poor response to conventional therapy, derived from hematopoietic progenitors committed to T-cell lineage. Relapsed/Refractory patients account for nearly 20% of childhood and 45% of adult cases. Aberrant Notch signaling plays a critical role in T-ALL pathogenesis and therapy resistance. Notch inhibition is a promising therapeutic target for personalized medicine, and a variety of strategies to prevent Notch activation, including γ-secretase (GS) inhibitors (GSIs) and antibodies neutralizing Notch receptors or ligands, have been developed. Disruption of apoptosis is pivotal in cancer development and progression. Different reports evidenced the interplay between Notch and the anti-apoptotic Bcl-2 family proteins in T-ALL. Although based on early research data, this review discusses recent advances in directly targeting Notch receptors and the use of validated BH3 mimetics for the treatment of T-ALL and their combined action in light of current evidence of their use.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Precursor T-Cell Lymphoblastic Leukemia-LymphomaReceptors, NotchApoptosisHumansProto-Oncogene Proteins c-bcl-2Antineoplastic AgentsSignal TransductionAnimalsAmyloid Precursor Protein Secretases

Stichwörter der Autor:innen

BH3 mimeticsBcl-2 family proteinsNotchNotch inhibitorsT-cell leukemia

Substanzen

Receptors, NotchProto-Oncogene Proteins c-bcl-2Antineoplastic AgentsAmyloid Precursor Protein Secretases

Autor:innen und Institutionen

  • Department of Experimental Medicine, Sapienza University of Rome, 00161 Rome, Italy.
  • Department of Molecular Medicine, Sapienza University of Rome, 00161 Rome, Italy.

ORCID-Profile: Ilaria Sergio, Maria Pia Felli

Förderung

  • Sapienza University

Zitieren

APA

Sergio, I., Varricchio, C., Squillante, F., Cantale Aeo, N. M., Campese, A. F., & Felli, M. P. (2024). Notch Inhibitors and BH3 Mimetics in T-Cell Acute Lymphoblastic Leukemia. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252312839

Vancouver

Sergio I, Varricchio C, Squillante F, Cantale Aeo NM, Campese AF, Felli MP. Notch Inhibitors and BH3 Mimetics in T-Cell Acute Lymphoblastic Leukemia. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252312839

BibTeX
@article{Sergio2024,
  author = {Sergio, Ilaria and Varricchio, Claudia and Squillante, Federica and Cantale Aeo, Noemi Martina and Campese, Antonio Francesco and Felli, Maria Pia},
  title = {Notch Inhibitors and BH3 Mimetics in T-Cell Acute Lymphoblastic Leukemia},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms252312839}
}
Kostenlos starten →